BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1162307)

  • 1. Delayed hypersensitivity in patients with bronchial carcinoma.
    Pauwels R; van der Straeten M
    Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Skin reactions of delayed hypersensitivity in melanoblastoma].
    Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
    Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene (DNCB) in patients with bronchial carcinoma].
    Ruszel KB
    Wiad Lek; 1978 Oct; 31(19):1341-4. PubMed ID: 716404
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correlation between immunological stage and response to chemotherapy. Results in 64 patients with nonresectable epidermoid bronchial cancers].
    Pouillart P; Botto G; Gauthier H; Huguenin P; Baron A; Laparre C; Hoang Thy HT; Parrot R; Mathé G
    Nouv Presse Med; 1976 Apr; 5(16):1037-42. PubMed ID: 1272771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
    Bolton PM
    Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the immunologic sensitizability of tumor patients].
    Hegemann F
    Arch Geschwulstforsch; 1968; 32(4):339-52. PubMed ID: 4308112
    [No Abstract]   [Full Text] [Related]  

  • 7. [Parameters of cellular immunity in subjects with bronchial squamous cell tumors].
    Vietti Ramus G; Tartaglino B; Cesano L; Revello F; Barbalonga A
    Minerva Med; 1983 Apr; 74(16):879-87. PubMed ID: 6601781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 9. The prognostic significance of DHS skin tests in patients with carcinoma of bronchus.
    Anthony HM; Templeman GH; Madsen KE; Mason MK
    Cancer; 1974 Dec; 34(6):1901-6. PubMed ID: 4373163
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immune response in patients with bronchial carcinoma. Relation between clinical parameters and various immunological tests for immune status investigation.
    Jansen HM; Esselink MT; Orie NG; The TH
    Neth J Med; 1979; 22(1):1-9. PubMed ID: 216940
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
    Wells SA; Melewicz FC; Christiansen C; Ketcham AS
    Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of immune reactivity and clinical status in cancer.
    Chretien PB; Catalona WJ; Twomey PL; Sample WF
    Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of DNCB and tuberculin skin tests in relation to the various histological types of pulmonary cancer].
    Soresi V; Invernizzi G; Schiraldi G; Borghini U; Sacerdoti C; Maruzzi M
    Boll Ist Sieroter Milan; 1981 Jul; 60(3):216-21. PubMed ID: 6275868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Skin tests of delayed hypersensitivity (tuberculin, DNCB) in the immunologic study of patients with primary cancer of the lung].
    Bariffi F; Illiano A; Tranfa CM; Del Prato B
    Arch Monaldi; 1978; 33(4):239-50. PubMed ID: 756707
    [No Abstract]   [Full Text] [Related]  

  • 15. [Delayed hypersensitivity response of the skin to 2,4-dinitrochlorobenzene and old tuberculin in patients with lung cancer].
    Fan XJ
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):333-6. PubMed ID: 6653356
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed hypersensitivity to DNCB and survival following radiation therapy in patients with solid malignant tumors.
    Hazra TA; Parks LC; Inalsingh A; Peeples W
    Radiology; 1975 May; 115(2):429-30. PubMed ID: 1144761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer].
    Kozielski J; Seweryn J
    Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed hypersensitivity reaction: its relation to tumor spread and prognosis.
    El-Domeiri AA
    Surg Annu; 1977; 9():343-50. PubMed ID: 882897
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of tuberculin skin reactivity by prior tuberculin skin testing.
    Thestrup-Pedersen K
    Immunology; 1975 Feb; 28(2):343-8. PubMed ID: 1123250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
    Maisel RH; Ogura JH
    Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.